Daten aus dem Cache geladen. Gonorrhea Therapeutics Market Size, Trends and Forecast 2024-2032 |...

Gonorrhea Therapeutics Market Size, Trends and Forecast 2024-2032

0
4

According to FutureWise analysis the market for gonorrhea therapeutics in 2023 was US$ 1.7 billion, and is expected to reach US$ 2.5 billion by 2031 at a CAGR of 5.3%.

The bacteria Neisseria gonorrhoeae is the source of the sexually transmitted disease gonorrhea. It frequently affects the urethra, eyes, throat, vagina, anus, and female reproductive tract since these are warm, wet bodily parts. Unprotected intercourse is how gonorrhea is spread from one person to another. If the mother is infected, the baby may become infected during delivery. Typically, symptoms appear two to fourteen days following exposure. Unfortunately, some gonorrhea sufferers never show any overt symptoms. When a person has no noticeable symptoms, they are more prone to infect other partners.

Because N. gonorrhoeae is capable of quickly gaining resistance to numerous antibiotic classes, gonococcal infections are currently a serious issue worldwide. The antibiotics sulfonamides, penicillin, tetracyclines, and fluoroquinolones have become less effective against N. gonorrhoeae over time. Cephalosporins are currently the first-line treatment, however there have lately been incidences of resistance to those drugs documented. In women, gonorrhea frequently has no symptoms, whereas in men, it frequently does. Females who experience symptoms typically present with vaginal discharge, dysuria, dyspareunia, abnormal uterine bleeding, lower abdomen pain, and/or rectal pain. Male symptoms include testicular or rectal pain, dysuria, and urethral discharge and/or itching. The most frequently affected anatomical sites are the urethra and cervix, followed by the anal and pharyngeal regions. On the initial clinical visit, empiric therapy for gonococcal infections is frequently given based on history considerations such sexual activity with a person who has a STI or a clinical exam suspected of a STI, such as penile drip or abnormal vaginal discharge.

The bacteria Neisseria gonorrhoeae is the prevalent sexually transmitted illness known as gonorrhea. Both men and women can be affected by the condition, which if untreated can cause major health issues like infertility and an elevated risk of HIV transmission. Due to growing gonorrhea prevalence and increased public awareness of the condition, the worldwide market for gonorrhea therapeutics has seen rapid expansion in recent years. A number of reasons, including the availability of efficient medications, rising healthcare costs, and growing disease awareness, are driving the gonorrhea therapeutics market.

Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Gonorrhea-Therapeutics-Market/9153

Gonorrhea Therapeutics Market Segmentation:

By Gonococcal Infection

  • Uncomplicated Gonococcal Infection
  • Gonococcal Arthritis
  • Gonococcal Meningitis and Endocarditis

By Treatment

  • Monotherapy
  • Dual Therapy

By Route of Administration

  • Oral
  • Injectable

By Gender

  • Women
  • Men

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in Gonorrhea Therapeutics Market:

  • Hologic, Inc.
  • Merck & Co.
  • Pfizer Inc.
  • AstraZeneca
  • Danaher
  • Abbott
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Lupin Pharmaceuticals
  • Teligent, Inc.
  • Bayer AG
  • GlaxoSmithKline Plc.
  • Novartis AG.
  • Allergan plc
  • Sanofi S.A.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Baxter International Inc.

Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=9153%20&type=discount

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Gonorrhea Therapeutics Market By Gonococcal Infection, By Treatment, By Route of Administration, By Gender, By Distribution Channel and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

FutureWise Research

Contact Person: Vinay Thaploo.

Email: sales@futurewiseresearch.com

Contact Number: Asia: +91 8605575209 | USA: +1 3477094931

Website: www.futurewiseresearch.com

Search
Categories
Read More
Food
Sweeten Your Day with Nerds Sweets in NZ
Nerds sweets are a delightful way to brighten up your day. These tiny, colorful candies are...
By Stock 4Shops 2025-01-20 05:38:29 0 27
Other
What is Enlightenment? The teachings of A Class In Wonders
What is Enlightenment?Thanks for wondering the questions that can come to your brain, even when...
By Realable Aliyan 2023-12-06 08:53:09 0 1كيلو بايت
Other
Air Motor Market Volume Forecast and Value Chain Analysis 2024-2030
Air Motor Market Growth or Demand Increase or Decrease for what contains ? The Air Motor...
By Swati Lavate 2024-07-17 11:44:58 0 643
Other
Material for AI: Unlocking the strength of Brilliant Observations
The Cornerstone of AI: Knowledge the significance Facts In that part, we research the important...
By Scot Brian 2023-06-01 10:25:20 0 1كيلو بايت